InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by BAUM MARK L, Chief Executive Officer. Director active across 4 companies, notably HARROW, INC.. Aggregated, 4 reports have been logged. Total volume traded: €517k. The latest transaction was filed on 14 May 2026 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
US$257,76610,000 shares@ US$25.77660.022% mcap100.0% of flow
Common Stock
SEC:0001493152-26-023321·
Ideal exit: 8 Feb 2027 (T+270)
€258,95910,000 shares@ €25.89590.022% mcap100.0% of flow
Common Stock
SEC:0001493152-26-023321:0·
Ideal exit: 8 Feb 2027 (T+270)
€264,471125,000 shares@ €2.11580.023% mcap100.0% of flow
Common Stock
SEC:0001493152-22-002006·
€264,471125,000 shares@ €2.11580.014% mcap100.0% of flow
Common Stock
SEC:0001493152-22-002006:0·
4 of 4 declarations
About BAUM MARK L
Mark L. Baum is the CEO of Harrow, Inc. and Harrow Health, Inc. In this role, he is responsible for the strategic and operational direction of the companies. With extensive experience in the healthcare sector, he focuses on innovation and enhancing services. His leadership is essential for achieving growth objectives and strengthening the companies' market position.
